| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Neurology, University of California, San Francisco, CA 94143; and
Rocky Mountain Multiple Sclerosis Center, Englewood, CO 80110
Multiple sclerosis (MS) lesions in the CNS are characterized by disseminated demyelination with perivascular infiltrates of macrophages, T cells, and B cells. To investigate the origin and characteristics of the B cell population found in MS plaque tissue, we performed molecular studies in 10 MS patients and 4 non-MS control samples. Ig transcripts from the perivascular infiltrated brain lesions were analyzed by complementary-determining region 3 spectratyping to ascertain the B cell heavy chain gene rearrangement repertoire expressed in MS brains. Significant rearrangement diversity and deviation from the normal Ig heavy (H) chain repertoire was observed. The cloning and sequencing of RT-PCR products from families VH1 and VH4 showed a correlation with the profiles obtained by spectratyping. Generally, restricted spectratyping patterns concurred with repetition of in-frame complementary-determining region 3 identical sequences. The analysis of heavy chain variable (VH), diversity (D), and joining (JH) gene segments revealed the increased usage of VH1–69, VH4–34, and VH4–39. Similarly, gene segments from families D2, D3, and JH4 were over-represented. The presence of restricted patterns of rearranged Ig mRNA within the plaque lesion suggests that Ab production in the demyelinating plaque is a local phenomenon and supports the idea that in MS an Ag-driven immune response might be responsible for demyelination.
This article has been cited by other articles:
|
|
 |
|
  V. Somers, C. Govarts, K. Somers, R. Hupperts, R. Medaer, and P. Stinissen Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates J. Immunol., March 15, 2008; 180(6): 3957 - 3963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Hauser, E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al. B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis N. Engl. J. Med., February 14, 2008; 358(7): 676 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Owens, K. M. Winges, A. M. Ritchie, S. Edwards, M. P. Burgoon, L. Lehnhoff, K. Nielsen, J. Corboy, D. H. Gilden, and J. L. Bennett VH4 Gene Segments Dominate the Intrathecal Humoral Immune Response in Multiple Sclerosis J. Immunol., November 1, 2007; 179(9): 6343 - 6351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas, M. Puopolo, R. Reynolds, and F. Aloisi Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain, April 1, 2007; 130(4): 1089 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kolln, H.-M. Ren, R.-R. Da, Y. Zhang, E. Spillner, M. Olek, N. Hermanowicz, L. G. Hilgenberg, M. A. Smith, S. van den Noort, et al. Triosephosphate Isomerase- and Glyceraldehyde-3-Phosphate Dehydrogenase-Reactive Autoantibodies in the Cerebrospinal Fluid of Patients with Multiple Sclerosis J. Immunol., October 15, 2006; 177(8): 5652 - 5658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krumbholz, D. Theil, S. Cepok, B. Hemmer, P. Kivisakk, R. M. Ransohoff, M. Hofbauer, C. Farina, T. Derfuss, C. Hartle, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment Brain, January 1, 2006; 129(1): 200 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. O'Connor, H. Appel, L. Bregoli, M. E. Call, I. Catz, J. A. Chan, N. H. Moore, K. G. Warren, S. J. Wong, D. A. Hafler, et al. Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein J. Immunol., August 1, 2005; 175(3): 1974 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cepok, B. Rosche, V. Grummel, F. Vogel, D. Zhou, J. Sayn, N. Sommer, H.-P. Hartung, and B. Hemmer Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis Brain, July 1, 2005; 128(7): 1667 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Burgoon, K. M. Keays, G. P. Owens, A. M. Ritchie, P. R. Rai, C. D. Cool, and D. H. Gilden Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies PNAS, May 17, 2005; 102(20): 7245 - 7250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krumbholz, D. Theil, T. Derfuss, A. Rosenwald, F. Schrader, C.-M. Monoranu, S. L. Kalled, D. M. Hess, B. Serafini, F. Aloisi, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma J. Exp. Med., January 18, 2005; 201(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hohlfeld and H. Wekerle Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines PNAS, October 5, 2004; 101(suppl_2): 14599 - 14606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Corcione, S. Casazza, E. Ferretti, D. Giunti, E. Zappia, A. Pistorio, C. Gambini, G. L. Mancardi, A. Uccelli, and V. Pistoia Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis PNAS, July 27, 2004; 101(30): 11064 - 11069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Ritchie, D. H. Gilden, R. A. Williamson, M. P. Burgoon, X. Yu, K. Helm, J. R. Corboy, and G. P. Owens Comparative Analysis of the CD19+ and CD138+ Cell Antibody Repertoires in the Cerebrospinal Fluid of Patients with Multiple Sclerosis J. Immunol., July 1, 2004; 173(1): 649 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Owens, A. M. Ritchie, M. P. Burgoon, R. A. Williamson, J. R. Corboy, and D. H. Gilden Single-Cell Repertoire Analysis Demonstrates that Clonal Expansion Is a Prominent Feature of the B Cell Response in Multiple Sclerosis Cerebrospinal Fluid J. Immunol., September 1, 2003; 171(5): 2725 - 2733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zocher, P. A. Baeuerle, T. Dreier, and A. Iglesias Specific depletion of autoreactive B lymphocytes by a recombinant fusion protein in vitro and in vivo Int. Immunol., July 1, 2003; 15(7): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Coronella, C. Spier, M. Welch, K. T. Trevor, A. T. Stopeck, H. Villar, and E. M. Hersh Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast J. Immunol., August 15, 2002; 169(4): 1829 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. von Budingen, S. L. Hauser, A. Fuhrmann, C. B. Nabavi, J. I. Lee, and C. P. Genain Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination PNAS, June 11, 2002; 99(12): 8207 - 8212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.E. Baranzini, K. Laxer, R. Saketkhoo, M.K. Elkins, J.M. Parent, R. Mantegazza, and J.R. Oksenberg Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis Neurology, March 12, 2002; 58(5): 709 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jacobsen, S. Cepok, E. Quak, M. Happel, R. Gaber, A. Ziegler, S. Schock, W. H. Oertel, N. Sommer, and B. Hemmer Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients Brain, March 1, 2002; 125(3): 538 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Williamson, M. P. Burgoon, G. P. Owens, O. Ghausi, E. Leclerc, L. Firme, S. Carlson, J. Corboy, P. W. H. I. Parren, P. P. Sanna, et al. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis PNAS, February 1, 2001; (2001) 31567598. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. H. Gilden, M. P. Burgoon, B. K. Kleinschmidt-DeMasters, R. A. Williamson, O. Ghausi, D. R. Burton, and G. P. Owens Molecular Immunologic Strategies to Identify Antigens and B-Cell Responses Unique to Multiple Sclerosis Arch Neurol, January 1, 2001; 58(1): 43 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Baranzini, C. Elfstrom, S.-Y. Chang, C. Butunoi, R. Murray, R. Higuchi, and J. R. Oksenberg Transcriptional Analysis of Multiple Sclerosis Brain Lesions Reveals a Complex Pattern of Cytokine Expression J. Immunol., December 1, 2000; 165(11): 6576 - 6582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Riemersma, E. S. Jordanova, R. F. J. Schop, K. Philippo, L. H. J. Looijenga, E. Schuuring, and P. M. Kluin Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites Blood, November 15, 2000; 96(10): 3569 - 3577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Colombo, M. Dono, P. Gazzola, S. Roncella, A. Valetto, N. Chiorazzi, G. L. Mancardi, and M. Ferrarini Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients J. Immunol., March 1, 2000; 164(5): 2782 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Williamson, M. P. Burgoon, G. P. Owens, O. Ghausi, E. Leclerc, L. Firme, S. Carlson, J. Corboy, P. W. H. I. Parren, P. P. Sanna, et al. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis PNAS, February 13, 2001; 98(4): 1793 - 1798. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
